Showing 20 of 43 recruiting trials for “graft-versus-host-disease”
A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
RecruitingNCT07127926 ↗
Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic GvHD
A Study to Evaluate Adrixetinib (Q702) in Adults With Active Chronic Graft-Versus-Host Disease
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
Electrostimulation Study for Ocular Graft vs. Host Disease
👨⚕️ Zhonghui Luo, MD, PhD, Massachusetts Eye and Ear Infirmary📍 1 site📅 Started Nov 2025View details ↗
BPC2001 for the Prevention of Acute Graft-Versus-Host Disease Following Haploidentical Stem Cell Transplantation
Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD
Ruxolitinib Plus Etanercept vs Ruxolitinib for Steroid-Refractory Severe Acute GVHD
A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CROSSOVER STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 μG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF OCULAR GRAFT-VERSUS-HOST DISEASE (OGVHD)
Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease
Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
👨⚕️ Stephanie J. Lee, MD, MPH, Fred Hutch/University of Washington Cancer Consortium📍 3 sites📅 Started Aug 2025View details ↗
Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT
👨⚕️ Xiaoyu Zhu, Ph.D, The First Affiliated Hospital of USTC📍 1 site📅 Started Jul 2025View details ↗
Gecacitinib for cGVHD: Safety and Efficacy in Patients After ≥2 Lines of Prior Therapy
A Ph1b/2 Study of Axatilimab Monotherapy in Chinese Participants With Recurrent or Refractory cGVHD
Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation
Effects of Omega-3 Fatty Acids on Acute Graft-versus-Host Disease After Allogeneic Stem Cell Transplantation.
👨⚕️ Ting Yang, MD, PhD, First Affiliated Hospital of Fujian Medical University📍 1 site📅 Started May 2025View details ↗
Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease
RecruitingNCT07314892 ↗
Psychiatric Status and Symptom Severity in Graft-versus-Host Disease (GvHD).
👨⚕️ Jan Puchowski, MD, Department of Hematology and Transplantology, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland Department of Psychiatry, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland📍 1 site📅 Started Apr 2025View details ↗
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
Page 1 of 3Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →